Asian head and neck cancer patients live longer with immunotherapy than mixed race group
LUGANO-SINGAPORE, 16 December, 2016 - Asian head and neck cancer patients live longer with the immunotherapy pembrolizumab than the overall population, according to a sub-analysis...